![Ori Kalid](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ori Kalid
Direttore Tecnico/Scientifico/R&S presso
PROTALIX BIOTHERAPEUTICS, INC.
Profilo
Ori Kalid was the founder of Pi Therapeutics Ltd., founded in 2015, and held the title of Chief Executive Officer.
Dr. Kalid is currently Vice President-Research & Development at Protalix Biotherapeutics, Inc. since 2024.
Formerly, Dr. Kalid was Chief Executive Officer at Pi Therapeutics Ltd. Dr. Kalid completed undergraduate, graduate, and doctorate degrees at Tel-Aviv University.
Posizioni attive di Ori Kalid
| Società | Posizione | Inizio |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/06/2024 |
Precedenti posizioni note di Ori Kalid
| Società | Posizione | Fine |
|---|---|---|
Pi Therapeutics Ltd.
 Pi Therapeutics Ltd. BiotechnologyHealth Technology Develops a proprietary cancer drug | Amministratore Delegato | - |
Pi Therapeutics Ltd.
Pi Therapeutics Ltd. BiotechnologyHealth Technology Develops a proprietary cancer drug | Amministratore Delegato | - |
Formazione di Ori Kalid
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
3
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics, Inc.
 Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
Pi Therapeutics Ltd.
Pi Therapeutics Ltd. BiotechnologyHealth Technology Develops a proprietary cancer drug | Health Technology |
